Inhibin A and B as predictive markers for chemotherapy-induced premature ovarian failure (POF) among premenopausal women with early stage breast cancer (ESBC).
Publication
, Conference
Anders, CK; Snyder, SA; Barrier, RC; Demark-Wahnefried, W; Welch, RA; Marcom, PK; Shaw, HS; Chui, SY; Blackwell, KL
Published in: BREAST CANCER RESEARCH AND TREATMENT
January 1, 2005
Duke Scholars
Published In
BREAST CANCER RESEARCH AND TREATMENT
ISSN
0167-6806
Publication Date
January 1, 2005
Volume
94
Start / End Page
S47 / S47
Location
San Antonio, TX
Publisher
SPRINGER
Conference Name
28th Annual San Antonio Breast Cancer Symposium
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Anders, C. K., Snyder, S. A., Barrier, R. C., Demark-Wahnefried, W., Welch, R. A., Marcom, P. K., … Blackwell, K. L. (2005). Inhibin A and B as predictive markers for chemotherapy-induced premature ovarian failure (POF) among premenopausal women with early stage breast cancer (ESBC). In BREAST CANCER RESEARCH AND TREATMENT (Vol. 94, pp. S47–S47). San Antonio, TX: SPRINGER.
Anders, C. K., S. A. Snyder, R. C. Barrier, W. Demark-Wahnefried, R. A. Welch, P. K. Marcom, H. S. Shaw, S. Y. Chui, and K. L. Blackwell. “Inhibin A and B as predictive markers for chemotherapy-induced premature ovarian failure (POF) among premenopausal women with early stage breast cancer (ESBC).” In BREAST CANCER RESEARCH AND TREATMENT, 94:S47–S47. SPRINGER, 2005.
Anders CK, Snyder SA, Barrier RC, Demark-Wahnefried W, Welch RA, Marcom PK, et al. Inhibin A and B as predictive markers for chemotherapy-induced premature ovarian failure (POF) among premenopausal women with early stage breast cancer (ESBC). In: BREAST CANCER RESEARCH AND TREATMENT. SPRINGER; 2005. p. S47–S47.
Anders, C. K., et al. “Inhibin A and B as predictive markers for chemotherapy-induced premature ovarian failure (POF) among premenopausal women with early stage breast cancer (ESBC).” BREAST CANCER RESEARCH AND TREATMENT, vol. 94, SPRINGER, 2005, pp. S47–S47.
Anders CK, Snyder SA, Barrier RC, Demark-Wahnefried W, Welch RA, Marcom PK, Shaw HS, Chui SY, Blackwell KL. Inhibin A and B as predictive markers for chemotherapy-induced premature ovarian failure (POF) among premenopausal women with early stage breast cancer (ESBC). BREAST CANCER RESEARCH AND TREATMENT. SPRINGER; 2005. p. S47–S47.
Published In
BREAST CANCER RESEARCH AND TREATMENT
ISSN
0167-6806
Publication Date
January 1, 2005
Volume
94
Start / End Page
S47 / S47
Location
San Antonio, TX
Publisher
SPRINGER
Conference Name
28th Annual San Antonio Breast Cancer Symposium
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences